TY  - GEN
AU  - Giovannetti,E
AU  - Labots,M
AU  - Dekker,H
AU  - Galvani,E
AU  - Lind,J S W
AU  - Sciarrillo,R
AU  - Honeywell,R
AU  - Smit,E F
AU  - Verheul,H M
AU  - Peters,G J
TI  - Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells
SN  - 1873-4286
PY  - 2013///0722
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Cycle
KW  - Cell Line, Tumor
KW  - Chromatography, Liquid
KW  - Drug Synergism
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Erlotinib Hydrochloride
KW  - Flow Cytometry
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lung Neoplasms
KW  - Molecular Targeted Therapy
KW  - Niacinamide
KW  - administration & dosage
KW  - Phenylurea Compounds
KW  - Phosphatidylethanolamine Binding Protein
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Sorafenib
KW  - Tandem Mass Spectrometry
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ER  -